Abstract
Dear Editor, We thank Dr. Piazzola and Prof. Castinetti for their insightful comments ( 1) on our study on long-term treatment of 36 patients with Cushing disease (CD) not cured by transsphenoidal surgery (TSS) ( 2). Drug treatment (DT) was initiated in 29/36 patients but it proved a long-term efficient treatment in only 38% (11/29). We agree that these results are provocative: How can we explain that DT was discontinued so frequently? First the authors are right to note that we gave priority to curative treatment, especially second TSS (2nd TSS), successful in 8/16 patients. These 8 patients included 5 in whom DT allowed a normal Urinary Free Cortisol, so that if we had not performed 2nd TSS in these 5 patients, the rate of patients with long-term control by DT would have been 55% (16/29). We think however that 2nd TSS was beneficial to these 5 patients: first, 2 were women with a short- or long-term aim of pregnancy, impossible with DT other than cabergoline, to which they were not sensitive; secondly the follow-up of all 5 patients, which is detailed in the manuscript favors the hypothesis that successful 2nd TSS may provide better clinical outcomes than DT, as already suggested by the HairCush study ( 3).

This publication has 5 references indexed in Scilit: